Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors

Cardiovascular Pathology

Volumn 23, Issue 4, 2014, Pages 204-210

  Sedgwick, Bryony ^a   Riches, Kirsten ^a   Bageghni, Sumia A ^a   O'Regan, David J ^a,b   Porter, Karen E ^a   Turner, Neil A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Cardiac fibroblasts; Heart; Human; Type 2 diabetes; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; COLLAGEN TYPE I, ALPHA 1 CHAIN; INSULIN RECEPTOR; INTERLEUKIN 1ALPHA;

ADULT; AGED; ARTICLE; CELL COUNTING; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; FIBROSIS; GENETICS; HEART ATRIUM REMODELING; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ATRIAL REMODELING; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; COLLAGEN TYPE I; DIABETES MELLITUS, TYPE 2; FIBROBLASTS; FIBROSIS; HUMANS; INTERLEUKIN-1ALPHA; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; PHENOTYPE; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84903706918     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.03.004     Document Type: Article

References (38)

1. L Chen, DJ Magliano, and PZ Zimmet The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives Nat Rev Endocrinol 8 2012 228 236
2. S Devaraj, MR Dasu, and I Jialal Diabetes is a proinflammatory state: a translational perspective Expert Rev Endocrinol Metab 5 2010 19 28
3. E Adeghate, and J Singh Structural changes in the myocardium during diabetes-induced cardiomyopathy Heart Fail Rev 19 2014 15 23
4. A Norhammar, and K Schenck-Gustafsson Type 2 diabetes and cardiovascular disease in women Diabetologia 56 2013 1 9
5. RM Cubbon, B Adams, A Rajwani, BN Mercer, PA Patel, G Gherardi, CP Gale, PD Batin, R Ajjan, L Kearney, SB Wheatcroft, RJ Sapsford, KK Witte, and MT Kearney Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology Diab Vasc Dis Res 10 2013 330 336
6. B Law, V Fowlkes, JG Goldsmith, W Carver, and EC Goldsmith Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function Microsc Microanal 18 2012 22 34
7. L van Heerebeek, N Hamdani, ML Handoko, I Falcao-Pires, RJ Musters, K Kupreishvili, AJ Ijsselmuiden, CG Schalkwijk, JG Bronzwaer, M Diamant, A Borbely, J van der Velden, GJ Stienen, GJ Laarman, HW Niessen, and WJ Paulus Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
8. MR Movahed, M Hashemzadeh, and MM Jamal Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 2005 315 318
9. J Jalife Mechanisms of persistent atrial fibrillation Curr Opin Cardiol 29 2014 20 27
10. KE Porter, and NA Turner Cardiac fibroblasts: at the heart of myocardial remodeling Pharmacol Ther 123 2009 255 278
11. NA Turner, and KE Porter Function and fate of myofibroblasts after myocardial infarction Fibrogenesis Tissue Repair 6 2013 5
12. SW van den Borne, J Diez, WM Blankesteijn, J Verjans, L Hofstra, and J Narula Myocardial remodeling after infarction: the role of myofibroblasts Nat Rev Cardiol 7 2010 30 37
13. S Neumann, K Huse, R Semrau, A Diegeler, R Gebhardt, GH Buniatian, and GH Scholz Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro Hypertension 39 2002 756 760
14. X Zhang, JA Stewart, ID Kane, EP Massey, DO Cashatt, and WE Carver Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix In Vitro Cell Dev Biol Anim 43 2007 297 305
15. VP Singh, KM Baker, and R Kumar Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production Am J Physiol Heart Circ Physiol 294 2008 H1675 H1684
16. J Asbun, AM Manso, and FJ Villarreal Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E Am J Physiol Heart Circ Physiol 288 2005 H227 H234
17. V Fowlkes, J Clark, C Fix, BA Law, MO Morales, X Qiao, K Ako-Asare, JG Goldsmith, W Carver, DB Murray, and EC Goldsmith Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts Life Sci 92 2013 669 676
18. KR Hutchinson, CK Lord, TA West, and JA Stewart Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes PLoS One 8 2013 e72080
19. KE Porter, NA Turner, DJ O'Regan, AJ Balmforth, and SG Ball Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA Cardiovasc Res 61 2004 745 755
20. 2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism Cardiovasc Res 57 2003 784 792
21. RS Mughal, P Warburton, DJ O'Regan, SG Ball, NA Turner, and KE Porter Peroxisome proliferator-activated receptor γ-independent effects of thiazolidinediones on human cardiac myofibroblast function Clin Exp Pharmacol Physiol 36 2009 478 486
22. 1A receptor internalisation Cell Signal 13 2001 269 277
23. NA Turner, A Das, P Warburton, DJ O'Regan, SG Ball, and KE Porter Interleukin-1α stimulates pro-inflammatory cytokine expression in human cardiac myofibroblasts Am J Physiol Heart Circ Physiol 297 2009 H1117 H1127
24. NA Turner, RS Mughal, P Warburton, DJ O'Regan, SG Ball, and KE Porter Mechanism of TNFα-induced IL-1α, IL-1β and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones Cardiovasc Res 76 2007 81 90
25. KD Copps, and MF White Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 Diabetologia 55 2012 2565 2582
26. K Cusi, K Maezono, A Osman, M Pendergrass, ME Patti, T Pratipanawatr, RA DeFronzo, CR Kahn, and LJ Mandarino Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 2000 311 320
27. NA Turner Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling Vascul Pharmacol 60 2014 1 7
28. NA Turner, P Warburton, DJ O'Regan, SG Ball, and KE Porter Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase Matrix Biol 29 2010 613 620
29. NA Turner, A Das, DJ O'Regan, SG Ball, and KE Porter Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation Int J Biochem Cell Biol 43 2011 1450 1458
30. FA van Nieuwenhoven, KE Hemmings, KE Porter, and NA Turner Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function Matrix Biol 32 2013 399 406
31. CH Mandavia, AR Aroor, VG Demarco, and JR Sowers Molecular and metabolic mechanisms of cardiac dysfunction in diabetes Life Sci 92 2013 601 608
32. A Daniels, D Linz, BM Van, H Rutten, T Sadowski, S Ruf, HP Juretschke, C Neumann-Haefelin, C Munts, GJ van Der Vusse, and FA van Nieuwenhoven Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats Eur J Heart Fail 14 2012 193 201
33. NA Turner, and KE Porter Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts IUBMB Life 64 2012 143 150
34. AC Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
35. PE Shamhart, DJ Luther, BR Hodson, JC Koshy, V Ohanyan, and JG Meszaros Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium Am J Physiol Endocrinol Metab 297 2009 E1147 E1153
36. SA Cook, A Varela-Carver, M Mongillo, C Kleinert, MT Khan, L Leccisotti, N Strickland, T Matsui, S Das, A Rosenzweig, P Punjabi, and PG Camici Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction Eur Heart J 31 2010 100 111
37. HA Madi, K Riches, P Warburton, DJ O'Regan, NA Turner, and KE Porter Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients Am J Physiol Cell Physiol 297 2009 C1307 C1317
38. M Asrih, and S Steffens Emerging role of epigenetics and miRNA in diabetic cardiomyopathy Cardiovasc Pathol 22 2013 117 125